The text discusses the issue of sectarianism in medicine, comparing it to sectarianism in religion, where individuals may condemn those with differing opinions and praise those who share their views. Dr. Beates argues that such attitudes are harmful to scientific progress and that true scientific progress requires a focus on facts and principles. He criticizes the use of unproven remedies and the tendency to rely on anecdotal evidence rather than rigorous scientific testing. He also highlights the importance of maintaining a spirit of scientific inquiry and avoiding prejudice in medical practice. The text then discusses the importance of the United States Pharmacopeia (USP) and the need for a more balanced representation of physicians and pharmacists in its revision process. Dr. Hatcher argues that the current composition of the committee is skewed towards pharmacists, which undermines the medical profession's role in shaping the pharmacopeia. He emphasizes the need for a more progressive approach to the inclusion and exclusion of drugs, ensuring that only those with proven efficacy are included. He also criticizes the inclusion of certain drugs, such as compound acetanilid powder, which he believes are not truly beneficial and may even be harmful. Dr. Hatcher further argues that the USP should be a reliable authority on drug purity and preparation, not just a reference book for pharmacists. He stresses the importance of clinical testing and pharmacological research in determining the safety and efficacy of drugs. He also highlights the need for the USP to be accessible to all physicians, not just those in academic settings, and to serve as a standard for drug quality and safety. The text then discusses the debate over the composition of the USP committee, with some arguing that it should include an equal number of physicians and pharmacists. Dr. Remington and others argue that the USP should be a standard for all physicians, not just those in academic settings. He also emphasizes the importance of the USP in providing a legal standard for drug purity and strength, and that it is the only such standard recognized by the U.S. government. The text concludes with a discussion on the need for a more balanced approach to the revision of the USP, with a focus on clinical testing and pharmacological research. It also highlights the importance of the USP in providing a reliable standard for drug quality and safety, and the need for all physicians to recognize its value. The text emphasizes the importance of scientific progress and the need for a more balanced approach to the revision of the USP.The text discusses the issue of sectarianism in medicine, comparing it to sectarianism in religion, where individuals may condemn those with differing opinions and praise those who share their views. Dr. Beates argues that such attitudes are harmful to scientific progress and that true scientific progress requires a focus on facts and principles. He criticizes the use of unproven remedies and the tendency to rely on anecdotal evidence rather than rigorous scientific testing. He also highlights the importance of maintaining a spirit of scientific inquiry and avoiding prejudice in medical practice. The text then discusses the importance of the United States Pharmacopeia (USP) and the need for a more balanced representation of physicians and pharmacists in its revision process. Dr. Hatcher argues that the current composition of the committee is skewed towards pharmacists, which undermines the medical profession's role in shaping the pharmacopeia. He emphasizes the need for a more progressive approach to the inclusion and exclusion of drugs, ensuring that only those with proven efficacy are included. He also criticizes the inclusion of certain drugs, such as compound acetanilid powder, which he believes are not truly beneficial and may even be harmful. Dr. Hatcher further argues that the USP should be a reliable authority on drug purity and preparation, not just a reference book for pharmacists. He stresses the importance of clinical testing and pharmacological research in determining the safety and efficacy of drugs. He also highlights the need for the USP to be accessible to all physicians, not just those in academic settings, and to serve as a standard for drug quality and safety. The text then discusses the debate over the composition of the USP committee, with some arguing that it should include an equal number of physicians and pharmacists. Dr. Remington and others argue that the USP should be a standard for all physicians, not just those in academic settings. He also emphasizes the importance of the USP in providing a legal standard for drug purity and strength, and that it is the only such standard recognized by the U.S. government. The text concludes with a discussion on the need for a more balanced approach to the revision of the USP, with a focus on clinical testing and pharmacological research. It also highlights the importance of the USP in providing a reliable standard for drug quality and safety, and the need for all physicians to recognize its value. The text emphasizes the importance of scientific progress and the need for a more balanced approach to the revision of the USP.